<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Medicare Drug Plan</title>
    <meta content="L21MED$03" name="slug"/>
    <meta content="21" name="publication_day_of_month"/>
    <meta content="7" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Friday" name="publication_day_of_week"/>
    <meta content="Editorial Desk" name="dsk"/>
    <meta content="18" name="print_page_number"/>
    <meta content="A" name="print_section"/>
    <meta content="6" name="print_column"/>
    <meta content="Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1216455"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Medicine and Health</classifier>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Law and Legislation</classifier>
        <classifier class="indexing_service" type="descriptor">Medicare</classifier>
        <location class="indexing_service">United States</location>
        <person class="indexing_service">Roth, William V Jr (Sen)</person>
        <person class="indexing_service">Linde, Brian</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion/Letters</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/North America</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/North America/United States</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicare</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Law and Legislation</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000721T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9505E3DB163AF932A15754C0A9669C8B63" item-length="91" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Medicare Drug Plan</hl1>
      </hedline>
      <abstract>
        <p>Brian Linde letter says Sen William Roth's drug plan would help the elderly but not younger Americans (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor</p>
        <p>Re ''A Solid Republican Drug Plan'' (editorial, July 15):</p>
        <p>Senator William V. Roth Jr.'s Medicare drug plan, though a step in the right direction, would not solve the problem of high drug costs. It would help the elderly pay for medicine, but would not help younger Americans. Government regulation of drug prices or government financing to lower the cost of medication for all Americans should be considered.</p>
        <p>BRIAN LINDE  New York, July 16, 2000</p>
      </block>
      <block class="full_text">
        <p>To the Editor</p>
        <p>Re ''A Solid Republican Drug Plan'' (editorial, July 15):</p>
        <p>Senator William V. Roth Jr.'s Medicare drug plan, though a step in the right direction, would not solve the problem of high drug costs. It would help the elderly pay for medicine, but would not help younger Americans. Government regulation of drug prices or government financing to lower the cost of medication for all Americans should be considered.</p>
        <p>BRIAN LINDE  New York, July 16, 2000</p>
      </block>
    </body.content>
  </body>
</nitf>
